Cardiovascular death in rheumatoid arthritis: a population-based study.

By H. Maradit-Kremers, P. Nicola, Cynthia S. Crowson, K. Ballman, S. Gabriel. Arthritis & Rheumatism, 2005

977 citations recorded by the source corpus.

Subfields: Nephrology, Rehabilitation, Rheumatology

View Paper: https://www.semanticscholar.org/paper/ba8491f470f015122c4a36be9414e68bb77b8059

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Rheumatology

Citations in the corpus

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. (2006, background): “†Not reported in original publication; on file with US Food and Drug Administration (http://www.fda.gov/_Hlt94332169o_Hlt94332169hrms/dockets/ac/03/briefing /3930B1_01_C--_Hlt103512168_Hlt103512168HUMIRA.Med.Review.pdf).”
Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. (2014, neutral): “Inflammatory conditions, such as arthritis, adversely influence the CV system so that patients with arthritis are afflicted with CV conditions to a significantly greater extent than the general population (125-128).”
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. (2005, result): “The first major finding of this study is the demonstration of a higher risk of both hospitalized and unrecognized MI prior to the clinical onset of RA. This finding is consistent with the absence of any association between cardiovascular mortality and RA disease duration in this cohort ( 36 ).”
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (2009, background): “31 Moreover, there is strong evidence showing that chronic inflammatory markers are independently associated with CV mortality and morbidity in RA.”